Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study
Condition(s) studied
Investigational drug(s) / intervention(s)
Endovascular treatment: Endovascular treatment, such as mechanical thrombectomy with stent, aspiration catheter or stent assisted by intermediate aspiration catheter, as well as combination of mechanical thrombectomy with intra-arterial thrombolysis
Study summary
A Multicenter Registry of Endovascular Treatment for Acute Ischemic Stroke.
Eligibility
Primary outcome measure(s)
- Functional outcome — 90days
Shift (improvement) in scores on the modified Rankin scale (mRS) at 90 days (±7 days). The value range 0-6: higher scores mean a worse outcome.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Jianimin Liu | Shanghai | China | Recruiting |
More Changhai Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05864638 on ClinicalTrials.gov ↗ ← All trials in China